Advertisement
Screener

Ionis Pharmaceuticals, Inc. (IONS) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Ionis Pharmaceuticals, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Ionis Pharmaceuticals, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $268.58M went out.
  • Fiscal year ended 2025-12-31: from investing, $277.78M went out.
  • Fiscal year ended 2025-12-31: from financing, $675.84M came in.
  • Fiscal year ended 2025-12-31: change in cash, $130.18M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksCommercial paperStaff share taxNew shares soldOtherNot split outChange in cash
2025-12-31-$268.58M-$277.78M$0.00$675.84M*$130.18M
2024-12-31-$500.95M-$134.03M$0.00$489.12M-$11.06M*-$157.19M
2023-12-31-$307.51M-$214.13M$0.00$0.00$644.08M*$122.79M
2022-12-31-$274.37M-$262.64M$0.00-$10.95M$0.00-$44.34M*-$592.72M
2021-12-31$30.80M$194.91M$0.00-$16.73M$262.66M*$471.53M
2020-12-31$35.89M$274.48M-$90.55M-$13.41M$0.00-$492.65M*-$285.62M
2019-12-31$345.63M-$41.27M-$34.40M-$19.24M$0.00$153.66M*$404.47M
2018-12-31$602.91M-$929.56M$0.00$0.00$0.00$447.96M$0.00$27.90M*$149.19M
2017-12-31$174.15M-$358.29M$0.00$0.00$0.00$71.74M$0.00$157.35M*$44.95M
2016-12-31-$112.11M$56.60M$4.00M$0.00$1.86M$5.53M*-$44.11M
2015-12-31$21.13M-$60.05M$8.50M$0.00$396.00K$15.83M*-$14.20M
2014-12-31$6.29M-$82.85M$0.00$0.00$1.46M$58.13M*
2013-12-31$63.49M-$255.73M$0.00$173.29M$0.00$54.43M*
2012-12-31$1.88M$18.00M$0.00$0.00$39.13M*
2011-12-31-$114.80M$110.90M-$672.00K*-$4.58M
2010-12-31-$63.59M$23.69M$4.70M*-$35.20M
2009-12-31-$108.44M-$212.29M$278.00K$201.72M*-$118.73M
2008-12-31$212.03M-$234.25M$49.96M$57.62M*$85.37M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksCommercial paperStaff share taxNew shares soldOtherNot split outChange in cash
2026-06-30$565.53M*$23.50M*-$412.29M*
2026-03-31-$792.82M$536.82M$57.26M*-$198.88M
2025-12-31-$137.71M*-$419.50M*$0.00*$591.18M*
2025-09-30-$131.44M*$91.34M*$81.22M*
2025-06-30$151.34M*-$120.07M*$1.25M*
2025-03-31-$150.78M$170.46M$2.20M*$22.11M
2024-12-31-$116.14M*$68.21M*$27.00K*-$44.14M*
2024-09-30-$114.99M*-$340.80M*$496.05M*
2024-06-30-$119.88M*$62.45M*$2.56M*
2024-03-31-$149.94M$76.11M$23.57M*-$50.38M
2023-12-31$32.87M*-$26.71M*$0.00*$0.00*$40.72M*
2023-09-30-$109.02M*$68.71M*$0.00*-$32.27M*
2023-06-30-$97.36M*$69.52M*$0.00*$143.54M*
2023-03-31-$133.99M-$325.64M$0.00$492.09M*$32.56M
2022-12-31-$200.19M*$212.15M*-$736.00K*-$50.28M*
2022-09-30-$24.43M*-$183.93M*-$645.00K*$2.48M*
2022-06-30-$18.10M*-$3.30M*-$399.00K*$1.61M*
2022-03-31-$31.65M-$287.55M-$9.17M$1.85M*-$326.68M
2021-12-31$203.69M*$95.11M*$0.00*-$440.00K*-$62.05M*
2021-09-30-$55.57M*$121.97M*$0.00*-$490.00K*$1.95M*
2021-06-30-$62.65M*-$101.03M*$0.00*-$458.00K*$315.00M*
2021-03-31-$54.66M$78.86M$0.00-$15.34M$7.76M*$16.49M
2020-12-31$97.98M*$187.85M*$0.00*-$451.00K*-$521.03M*
2020-09-30-$10.28M*$101.94M*$0.00*-$989.00K*$11.93M*
2020-06-30-$44.22M*$79.69M*-$48.00K*-$368.00K*$8.85M*
2020-03-31-$7.59M-$95.01M-$90.50M-$11.60M$7.60M*-$197.09M
2019-12-31$277.84M*$138.19M*-$401.00K*$0.00*$19.63M*
2019-09-30-$12.81M*$1.40M*$0.00*-$10.81M*$0.00*-$2.37M*
2019-06-30-$27.11M*-$110.69M*$0.00*-$437.00K*$34.95M*
2019-03-31$107.70M-$70.17M$0.00-$7.60M$67.06M*$96.99M
2018-12-31$115.51M*-$326.21M*$0.00*$0.00*$9.65M*-$201.07M*
2018-09-30-$26.00M*-$307.67M*$0.00*$0.00*$8.08M*-$325.60M*
2018-06-30$500.24M*-$375.17M*$0.00*$447.96M*$4.95M*$577.99M*
2018-03-31$13.16M$79.49M$0.00$0.00$5.22M*$97.88M
2017-12-31$20.40M*-$54.21M*$0.00*$0.00*$4.26M*-$29.55M*
2017-09-30$28.72M*-$150.10M*$97.00K*$147.47M*$26.19M*
2017-06-30$2.36M*$14.70M*$0.00*$1.71M*$18.77M*
2017-03-31$122.67M-$168.68M$71.64M$3.91M*$29.54M
2016-12-31-$26.84M*$20.80M*$0.00*$0.00*$6.45M*$410.00K*
2016-09-30$24.29M*-$57.09M*$0.00*$4.54M*-$28.26M*
2016-06-30-$33.78M*$53.46M*$0.00*
2016-03-31-$75.77M$39.43M$0.00$879.00K*
2015-12-31-$37.47M*$27.96M*$8.50M*$3.21M*
2015-09-30$36.22M*-$29.28M*
2015-06-30$65.21M*-$95.39M*$1.32M*
2015-03-31-$42.83M$36.65M$11.53M*
2014-12-31$70.68M*-$50.79M*$0.00*$49.88M*
2014-09-30$1.94M*-$24.49M*$0.00*$1.68M*
2014-06-30-$34.02M*-$32.39M*-$1.29M*
2014-03-31-$32.33M$24.82M$9.31M*
2013-12-31-$14.49M*-$85.27M*$0.00*$3.33M*
2013-09-30$65.82M*-$123.31M*$69.00K*$17.29M*
2013-06-30$22.74M*-$31.84M*$197.99M*
2013-03-31-$10.58M-$15.31M$9.05M*
2012-12-31$36.03M*$5.04M*-$1.15M*
2012-09-30-$24.87M*-$10.61M*$34.40M*-$1.08M*
2012-06-30-$2.58M*$24.09M*$7.74M*$29.25M*
2012-03-31-$6.71M-$522.00K-$1.85M*-$9.09M
2011-12-31-$25.61M*$35.24M*$585.00K*$10.21M*
2011-09-30-$23.17M*-$5.70M*-$888.00K*-$29.76M*
2011-06-30-$26.18M*$24.64M*-$1.18M*
2011-03-31-$39.84M$56.72M-$728.00K*$16.15M
2010-12-31-$25.50M*-$7.24M*$2.67M*-$30.07M*
2010-09-30-$21.43M*$75.91M*$54.08M*
2010-06-30$5.03M*-$59.94M*$2.35M*-$52.55M*
2010-03-31-$21.69M$14.96M-$6.67M
2009-12-31-$31.36M*-$15.21M*$108.00K*$2.43M*-$44.04M*
2009-09-30-$32.26M*-$39.43M*$62.00K*$5.13M*-$66.50M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Spyre Therapeutics, Inc. (SYRE)United States$7.685B-43.69
Structure Therapeutics Inc. (GPCR)United States$7.710B-53.41
Alkermes plc. (ALKS)$6.844B132.74
RHYTHM PHARMACEUTICALS, INC. (RYTM)United States$6.771B-37.20
Praxis Precision Medicines, Inc. (PRAX)United States$7.884B-27.60
Liquidia Corp (LQDA)United States$6.347B51.23
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10